Use of human recombinant erythropoietin to correct severe preoperative anemia.
 The risks of homologous blood transfusion are well known.
 Herein, we describe the successful preoperative use of human recombinant erythropoietin to correct severe anemia in a patient refusing transfusion.
 This case report emphasizes the important perioperative role human recombinant erythropoietin may play in the future.
